SCAP and metabolic dysfunction-associated steatohepatitis: LMs are critical in the progression from fatty liver to NASH (47–49), and, indeed, SCAP-dependent changes in hepatocytic lipid metabolism play a crucial role in producing gained rhythms of genes related to inflammation in KCs.